Physician profile
Bryan M Saltzman
NPI 1316385719
$28,603.03
in general payments reported to CMS, 2019-2025
12 companies · $183 in 2025
The $183 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,320 · 2021: $837 · 2022: $5,436 · 2023: $2,370 · 2024: $3,139 · 2025: $183.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,404 · Travel and Lodging: $1,905 · Food and Beverage: $1,382.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,404.42 |
| Travel and Lodging | $1,904.59 |
| Food and Beverage | $1,382.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Peerless Surgical INC. | $14,190.44 | 2019-2023 | |
| Arthrex, INC. | $6,147.74 | 2019-2023 | |
| Smith+Nephew, INC. | $4,218.84 | 2019-2025 | Fast-Fix, Bone Anchors With Arthroscopic Delivery System, Healicoil |
| Stryker Corporation | $2,477.18 | 2023-2024 | Tornier Perform Reversed Glenoid, Blueprint Patient Specific Instrumentation |
| Bioventus LLC | $696.00 | 2021 | |
| Medacta USA, INC. | $285.80 | 2024-2025 | Reverse Shoulder |
| Depuy Synthes Sales INC. | $185.50 | 2019-2023 | Cor |
| Djo, LLC | $149.38 | 2019 | |
| Rti Surgical, INC | $130.32 | 2024 | |
| Vericel Corporation | $51.29 | 2019-2024 | Maci |
| Mf Med | $48.49 | 2025 | |
| Zimmer Biomet Holdings, INC. | $22.05 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Saltzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.